Thus, alternative noninvasive strategies, such as serum biomarkers (ALT/AST ratio, APR Index, BARD score, NAFLD fibrosis score, FIB-4 index, exosomal miRNAs), and imaging techniques (elastography) have made great strides over the past decade (20, 21). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.